🕵️ DANA Inc ($DAN)
SEC insider & ownership activity, last 12 months · CIK 26780 · every row links its SEC filing
Over the last 12 months insiders sold $517K with no open-market buying against it. Price Michael Craig sold $298K (Nov). Blackrock, Inc. added 13.4% → 14.5%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $517K (39 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Price Michael Craig | 0 | – | 11 | $298K | Nov 25, 2025 |
| James D. Kellett | 0 | – | 28 | $219K | Aug 13, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.5% | 13G | Jan 21, 2026 | filing ↗ | |
| Dimensional Fund Advisors LP | 7.6% | 13G | Apr 9, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 7.3% | 13G | Apr 29, 2026 | filing ↗ | |
| American Century Investment Management, Inc. | 5.6% | 13G | May 1, 2026 | filing ↗ | |
| American Century Companies, Inc. | 5.6% | 13G | May 1, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 5.6% | 13G | May 1, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.5% | 13G | Apr 29, 2026 | filing ↗ | |
| American Century ETF Trust | 5.4% | 13G | May 1, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Price Michael Craig | $1.3M | Feb 18, 2026 | filing ↗ |
| Craig C. Price | $298K | Nov 25, 2025 | filing ↗ |
| James Kellett | $219K | Aug 13, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 10, 2026 | filing ↗ |
| Other events (8.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 21, 2026 | filing ↗ |